Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Tijdschrift Voor Kindergeneeskunde|June 1, 1989
[Neurofibromatosis in pediatrics]P Fleury, A de Goede-Bolder
The Netherlands Journal of Medicine|January 12, 1999
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumE P Mauser-Bunschoten, A de Goede-Bolder, J J Wielenga, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2001
[From gene to disease; neurofibromatosis type 1]A de Goede-Bolder, M H Cnossen, D Dooijes, et al.
European Journal of Pediatrics|June 1, 1997
Diagnostic delay in neurofibromatosis type 1M H Cnossen, F J Smit, A de Goede-Bolder, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 31, 2012
The group medical appointment (GMA) in haemophilia and von Willebrand's disease: a new development in outpatient paediatric careJ Lock, A De Bruin, M Scholten, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort studyI Plug, J G Van Der Bom, M Peters, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 15, 2010
Health-related quality of life in preschool children in five health conditionsA T Spuijbroek, R Oostenbrink, J M Landgraf, et al.
AJNR. American Journal of Neuroradiology|March 15, 2008
Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imagingS J P M van Engelen, L C Krab, H A Moll, et al.
Pediatrics|October 2, 1997
Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1M H Cnossen, E N Stam, L C Cooiman, et al.
Pageof 2